Former Amylin Pharmaceuticals Chief Executive Officer brings more than 40 years of experience building and leading life sciences companies Daniel M. Bradbury, Chairman of the Board of Directors Conexeu Sciences Inc. Nasd
Why Is CNXU (CNXU) Stock Down Today?
Updated Nov 22, 2026 8:06 AM ET ยท Prev Close $2.08
Session Regime & Catalyst Assessment
68% Signal ConvictionCNXU Pulling Back 25.48% on 2.40x Relative Volume
Cnxu (Cnxu) is pulling back 25.48% (-$0.53) to $1.55 on 2.40x average session volume. Relative to benchmarks, CNXU is lagging the S&P 500 by -21.84%. 14-day RSI stands at 29.8, keeping momentum in a oversold regime.
Former Amylin Pharmaceuticals Chief Executive Officer brings more than 40 years of experience building and leading life sciences companies Daniel M. Bradbury, Chairman of the Board of Directors Conexeu Sciences Inc. Nasd
Price ($1.55) trades relative to 20-day SMA ($2.34) and 50-day SMA ($3.23).
Market & Sector Relative Strength
CNXU lagging the S&P 500 by -21.84%Options Flow & Execution Desk
Recent CNXU Catalyst Headlines
Verified WireNew fabricated formats in development for wounds from broad surfaces to large volumetric defects planned FDA 510 k submission for the flowable lead device candidate continues to target the first calendar quarter of 2027H
CXU formula already evaluated with human collagen in the 12-month P.R.O.O.F. preclinical study first pilot batch of Conexeu s own human collagen met predefined Company specificationsHighlights Conexeu has launched a huma
Financing involving participation from the CEO and Chief Commercial Officer, supports manufacturing scale-up, regulatory testing and preclinical work toward the Company s planned FDA 510 k submission in the first quarter
1โ3 Day Expected Range & Key Level
54% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $1.48 (session support) for directional breakout confirmation.
Technical Regime (CNXU)
BEARISH MA TRENDAbout CNXU
Get Instant CNXU Catalyst Alerts
Receive an email alert when CNXU triggers an unusual volume breakout, options sweep, or rating shift.
CNXU Session & Catalyst FAQ
Why is CNXU stock down today?
Cnxu (Cnxu) is pulling back 25.48% (-$0.53) to $1.55 on 2.40x average session volume. Relative to benchmarks, CNXU is lagging the S&P 500 by -21.84%. 14-day RSI stands at 29.8, keeping momentum in a oversold regime.
Is CNXU stock a buy or sell right now?
Today's session carries a 68% catalyst conviction score on 2.40x relative volume (high participation). Our multi-factor model currently rates CNXU as HOLD. Review full valuation, quality, and timing signals on the CNXU Buy or Sell Decision Brief โ
What is CNXU's intrinsic value and expected trading range?
At $1.55, CNXU's modeled 1-to-3 session range is $1.46 โ $1.64, with a key inflection level at $1.48 (session support). Compare current price against multi-year cash flow projections in the CNXU Intrinsic Value & DCF Model โ and Market Cycle Phase Tracker โ
What do RSI and moving averages signal for CNXU?
RSI at 29.8 indicates oversold conditions โ watch for mean-reversion support. CNXU trades at $1.55 relative to its 20-day SMA ($2.34) and 50-day SMA ($3.23), reflecting a bearish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.